By Assoc. Prof. Dr. Mehmet Sorar | Published: 05.02.2025
What is Parkinson’s Disease?
Parkinson’s disease is a progressive brain condition that mainly affects movement but also reaches mood, sleep and pain. The World Health Organization (WHO) lists slow movement, tremor, rigidity and walking and balance difficulty as its movement features. Doctors diagnose it from your history and an examination. There is no cure, but medicines, therapy and, for some people, surgery can ease symptoms.
What are the movement symptoms of Parkinson’s disease?
WHO describes four movement features: slow movement, tremor, rigidity (stiff muscles), and difficulty with walking and balance. The 2015 diagnostic criteria of the International Parkinson and Movement Disorder Society (MDS) define parkinsonism, the Parkinson-like picture, as bradykinesia (slowness of movement) plus rest tremor, rigidity, or both.
| Feature | Where it appears in the definitions |
|---|---|
| Slowness of movement (bradykinesia) | Always required in the MDS definition of parkinsonism. Also on the WHO list. |
| Rest tremor | One of the two findings that can accompany slowness (MDS). |
| Rigidity | The other finding that can accompany slowness (MDS). |
| Walking and balance difficulty | On the WHO list of movement features. |
Not everyone has every feature. Under the MDS definition, slowness together with rigidity still counts as parkinsonism even when there is no tremor.
Which symptoms have nothing to do with movement?
WHO lists cognitive impairment, mental health disorders, dementia, sleep disorders, pain and sensory disturbances as non-motor features. A 2021 review in The Lancet adds that clinically obvious Parkinson’s can be preceded by a potentially long prodromal period, the early phase before the typical picture appears. For now, the review says, recognising this phase changes nothing beyond relieving symptoms.
How is Parkinson’s disease diagnosed?
Diagnosis is clinical, which means it rests on history and examination. WHO says neurologists can make it and, where specialists are scarce, trained non-specialist health workers can too. The Lancet review says additional tests are kept for atypical presentations, meaning cases that do not look typical.
The MDS criteria work in two steps. Parkinsonism is documented first. Then the decision that Parkinson’s disease is the cause rests on three groups of features:
- Absolute exclusion criteria, which rule Parkinson’s disease out.
- Red flags, which must be balanced by supportive criteria.
- Supportive criteria, positive features that raise confidence in the diagnosis.
Two certainty levels are defined. “Clinically established” Parkinson’s favours specificity (avoiding a wrong diagnosis) over sensitivity, while “probable” Parkinson’s balances the two. The benchmark is an expert’s clinical diagnosis, and the aim is to let less experienced clinicians reach the same answer. The authors say the criteria were written for research, may also guide clinical diagnosis, and will need continuous revision.
What causes it, and how many people have it?
The causes are only partly understood. The Lancet review reports that in most populations 3 to 5% of Parkinson’s disease is explained by known Parkinson’s genes. About 90 genetic risk variants together explain 16 to 36% of the inherited risk of the form that is not caused by a single gene. Having a relative with Parkinson’s or tremor, having constipation, and not smoking each at least doubled the risk. These are statistical associations, not advice.
WHO estimates that more than 8.5 million people were living with Parkinson’s in 2019 and that prevalence had doubled in the previous 25 years. It attributes 5.8 million disability-adjusted life years (a measure of total health burden) to the disease, up 81% since 2000, and 329,000 deaths, up more than 100% since 2000.
How is Parkinson’s disease treated?
The Lancet review names levodopa as the most common first-line medicine and says management should begin at diagnosis with a multidisciplinary team, including non-drug care. It also states that no therapy can currently slow or stop progression. The NHS, the UK’s public health service, explains that levodopa is converted to dopamine in the brain and that most people eventually need it. Other medicines include dopamine agonists, which act like dopamine with a milder effect, MAO-B inhibitors, used early with smaller effects, and COMT inhibitors, used later to make levodopa work for longer.
For on-off fluctuations (swings between good and poor control) that are hard to control, the NHS lists apomorphine injections or pump infusion and pump-delivered levodopa. It describes physiotherapy, occupational therapy, speech and language therapy and dietary advice as non-drug care, and WHO adds that physiotherapy can improve functioning. Surgery is covered separately: see which operations exist for Parkinson’s, the evidence on deep brain stimulation in Parkinson’s, and how strong the evidence is for newer approaches.
When should you see a doctor?
Arrange an assessment if you notice any of these:
- Slowing of movement, especially together with tremor at rest or stiffness.
- Trouble walking or keeping your balance.
- Sleep, mood, thinking or pain problems that are new or getting worse.
There is no set time limit for a first assessment, but the Lancet review says there is no reason to postpone symptomatic treatment once a person becomes disabled by the condition. Choosing whom to see is covered in how to choose a Parkinson’s doctor.
If you already take Parkinson’s medicines, tell your treating team about hallucinations, confusion, or urges such as compulsive gambling or shopping. The NHS says dopamine agonists can cause these, especially at high doses, and that you may not notice them yourself, so carers are asked to watch for them. Sudden sleep onset is rare but serious, and driving is usually avoided while a dose is being increased. Do not stop or change your medicines on your own, and raise any of these problems with the team first.
Sudden changes are different. If your face droops on one side, you cannot lift an arm, or your speech becomes slurred or confused, the NHS says to call emergency services at once, even if the signs stop, because these can mean a stroke. In Türkiye the number is 112.
Sources
This article is for general information and does not replace medical diagnosis or treatment. Please consult your physician for advice about your own condition.
Assoc. Prof. Dr. Mehmet Sorar
Neurosurgeon in Ankara. Graduated from Gazi University Faculty of Medicine in 1997, specialist since 2004, associate professor since 2019. Full CV
Related treatment page: Parkinson